Article
Transcriptome profiling of NIH3T3 cell lines expressing opsin and the P23H opsin mutant identifies candidate drugs for the treatment of retinitis pigmentosa.
Pharmacological research - 1 Jan 2017
Chen Yuanyuan, Brooks Matthew J, Gieser Linn, Swaroop Anand, Palczewski Krzysztof
Abstract excerpt
Mammalian cells are commonly employed in screening assays to identify active compounds that could potentially affect the progression of different human diseases including retinitis pigmentosa (RP), a class of inherited diseases causing retinal degeneration with compromised vision. Using transcriptome analysis, we compared NIH3T3 cells expressing wildtype (WT) rod opsin with a retinal disease-causing single P23H...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
